Professional Documents
Culture Documents
VerDate Aug<31>2005 16:50 Mar 18, 2008 Jkt 214001 PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 E:\FR\FM\19MRN1.SGM 19MRN1
14840 Federal Register / Vol. 73, No. 54 / Wednesday, March 19, 2008 / Notices
substances may file comments or of Kenco Group, Inc., 350 Corporate DEPARTMENT OF JUSTICE
objections to the issuance of the Place, Chattanooga, Tennessee 37419,
proposed registration and may, at the made application by renewal to the Drug Enforcement Administration
same time, file a written request for a Drug Enforcement Administration
hearing on such application pursuant to Manufacturer of Controlled
(DEA) to be registered as an importer of
21 CFR 1301.43 and in such form as Substances; Notice of Application
Nabilone (7379), a basic class of
prescribed by 21 CFR 1316.47. controlled substance listed in schedule Pursuant to § 1301.33(a) of Title 21 of
Any such comments or objections II. the Code of Federal Regulations (CFR),
being sent via regular mail should be this is notice that on November 30,
addressed, in quintuplicate, to the Drug The company plans to import the
listed controlled substance for 2007, Mallinckrodt Inc., 3600 North
Enforcement Administration, Office of Second Street, St. Louis, Missouri
Diversion Control, Federal Register distribution to its customers.
63147, made application by renewal to
Representative (ODL), Washington, DC Any bulk manufacturer who is the Drug Enforcement Administration
20537, or any being sent via express presently, or is applying to be, (DEA) to be registered as a bulk
mail should be sent to Drug registered with DEA to manufacture manufacturer of the basic classes of
Enforcement Administration, Office of such basic class of controlled substance controlled substances listed in
Diversion Control, Federal Register may file comments or objections to the schedules I and II:
Representative (ODL), 8701 Morrissette issuance of the proposed registration
Drive, Springfield, VA 22152; and must and may, at the same time, file a written Drug Schedule
be filed no later than April 18, 2008. request for a hearing on such
This procedure is to be conducted Tetrahydrocannabinols (7370) ..... I
application pursuant to 21 CFR 1301.43 Codeine-N-oxide (9053) ............... I
simultaneously with, and independent
and in such form as prescribed by 21 Dihydromorphine (9145) ............... I
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted CFR 1316.47. Difenoxin (9168) ........................... I
Any such comments or objections Morphine-N-oxide (9307) ............. I
in a previous notice published in the Normorphine (9313) ..................... I
Federal Register on September 23, 1975, being sent via regular mail should be Norlevorphanol (9634) .................. I
(40 FR 43745), all applicants for addressed, in quintuplicate, to the Drug Amphetamine (1100) .................... II
registration to import a basic class of Enforcement Administration, Office of Methamphetamine (1105) ............ II
any controlled substances in schedule I Diversion Control, Federal Register Methylphenidate (1724) ................ II
or II are, and will continue to be, Representative (ODL), Washington, DC Nabilone (7379) ............................ II
required to demonstrate to the Deputy 20537, or any being sent via express Codeine (9050) ............................. II
Assistant Administrator, Office of Diprenorphine (9058) ................... II
mail should be sent to Drug Etorphine HCL (9059) .................. II
Diversion Control, Drug Enforcement Enforcement Administration, Office of Dihydrocodeine (9120) ................. II
Administration, that the requirements Diversion Control, Federal Register Oxycodone (9143) ........................ II
for such registration pursuant to 21 Representative (ODL), 8701 Morrissette Hydromorphone (9150) ................ II
U.S.C. 958(a); 21 U.S.C. 823(a); and 21 Drive, Springfield, VA 22152; and must Diphenoxylate (9170) ................... II
CFR 1301.34(b), (c), (d), (e), and (f) are be filed no later than April 18, 2008. Ecgonine (9180) ........................... II
satisfied. Hydrocodone (9193) ..................... II
This procedure is to be conducted Levorphanol (9220) ...................... II
Dated: March 11, 2008.
simultaneously with, and independent Meperidine (9230) ........................ II
Joseph T. Rannazzisi, of, the procedures described in 21 CFR Methadone (9250) ........................ II
Deputy Assistant Administrator, Office of 1301.34(b), (c), (d), (e) and (f). As noted Methadone intermediate (9254) ... II
Diversion Control, Drug Enforcement Metopon (9260) ............................ II
Administration.
in a previous notice published in the Dextropropoxyphene, bulk (9273) II
Federal Register on September 23, 1975, Morphine (9300) ........................... II
[FR Doc. E8–5525 Filed 3–18–08; 8:45 am]
(40 FR 43745–46), all applicants for Thebaine (9333) ........................... II
BILLING CODE 4410–09–P
registration to import a basic class of Opium extracts (9610) .................. II
any controlled substances in schedule I Opium fluid extract (9620) ............ II
or II are and will continue to be required Opium tincture (9630) .................. II
DEPARTMENT OF JUSTICE Opium, powdered (9639) ............. II
to demonstrate to the Deputy Assistant Opium, granulated (9640) ............ II
Drug Enforcement Administration Administrator, Office of Diversion Levo-alphacetylmethadol (9648) .. II
Control, Drug Enforcement Oxymorphone (9652) ................... II
Importer of Controlled Substances; Administration, that the requirements Noroxymorphone (9668) .............. II
Notice of Application for such registration pursuant to 21 Phenazocine (9715) ..................... II
U.S.C. 958(a); 21 U.S.C. 823(a); and 21 Alfentanil (9737) ........................... II
Pursuant to 21 U.S.C. 958(i), the Remifentanil (9739) ...................... II
Attorney General shall, prior to issuing CFR 1301.34(b), (c), (d), (e), and (f) are Sufentanil (9740) .......................... II
a registration under this Section to a satisfied. Fentanyl (9801) ............................ II
bulk manufacturer of a controlled Dated: March 11, 2008.
substance in schedule I or II and prior The firm plans to manufacture the
Joseph T. Rannazzisi,
to issuing a registration under 21 U.S.C. listed controlled substances for internal
952(a)(2) authorizing the importation of Deputy Assistant Administrator, Office of use and for sale to other companies.
such a substance, provide Diversion Control, Drug Enforcement Any other such applicant and any
Administration.
manufacturers holding registrations for person who is presently registered with
the bulk manufacture of the substance [FR Doc. E8–5529 Filed 3–18–08; 8:45 am] DEA to manufacture such substances
jlentini on PROD1PC65 with NOTICES
an opportunity for a hearing. BILLING CODE 4410–09–P may file comments or objections to the
Therefore, in accordance with Title 21 issuance of the proposed registration
Code of Federal Regulations (CFR), pursuant to 21 CFR 1301.33(a).
1301.34(a), this is notice that on Any such written comments or
December 3, 2007, Kenco VPI, Division objections being sent via regular mail
VerDate Aug<31>2005 16:50 Mar 18, 2008 Jkt 214001 PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 E:\FR\FM\19MRN1.SGM 19MRN1